# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000593
Filing Date
2024-05-06
Accepted
2024-05-06 16:07:34
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cldx-20240331x10q.htm iXBRL | 10-Q | 1069533
2 | EX-31.1 | cldx-20240331xex31d1.htm | EX-31.1 | 13475
3 | EX-31.2 | cldx-20240331xex31d2.htm | EX-31.2 | 13334
4 | EX-32.1 | cldx-20240331xex32d1.htm | EX-32.1 | 6653
| Complete submission text file | 0001410578-24-000593.txt |  | 5227772

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | cldx-20240331.xsd | EX-101.SCH | 32153
6 | EX-101.CAL | cldx-20240331_cal.xml | EX-101.CAL | 39643
7 | EX-101.DEF | cldx-20240331_def.xml | EX-101.DEF | 137612
8 | EX-101.LAB | cldx-20240331_lab.xml | EX-101.LAB | 329505
9 | EX-101.PRE | cldx-20240331_pre.xml | EX-101.PRE | 236341
67 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20240331x10q_htm.xml | XML | 974723

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 24917532
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)